 |
|
|
Cardiovascular Biomedicine
Disorders of the cardiovascular system are the most frequent cause of death in the western hemisphere. The Cardiovascular Biomedicine team aims at improving the physiological understanding of both the developing and the diseased heart. Current work includes deciphering the most essential cardiac functions, i.e. initiation and regulation of spontaneous electrical activity. For this purpose, molecular, cell biological and physiological techniques are combined with transgenic mouse and embryonic stem cell models. A major focus is the improvement of heart function after an irreversible loss of heart cells. This strategy is currently evaluated by experimental transplantation of primary and stem cell-derived heart cells into the infarcted mouse heart.
Team leader:
Bernd Fleischmann
Telephone +49 228 6885 200
Facsimile +49 228 6885 201
|
|
